MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 10.53 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $27.386 million which missed the analyst consensus estimate of $30.620 million by 10.56 percent. This is a 12.70 percent increase over sales of $24.300 million the same period last year.